Fatima S. Cardoso

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 206 publications

Podcast: Patient voices and clinical advances-Elinzanetant for menopause symptom management associated with breast cancer treatment in the OASIS-4 trial.

Podcast: Patient voices and clinical advances-Elinzanetant for menopause symptom management associated with breast cancer treatment in the OASIS-4 trial.

Journal: Women's health (London, England)

Published: July 28, 2026

Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial Results.

Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial Results.

Journal: Women's health (London, England)

Published: July 14, 2026

Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress.

Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress.

Journal: Frontiers in nutrition

Published: June 09, 2026

Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.

Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.

Journal: Maturitas

Published: April 15, 2026

ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.

ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.

Journal: Annals of surgical oncology

Published: March 12, 2026

International comparisons of survival after recurrent metastatic breast cancer in four countries: A population-based study.

International comparisons of survival after recurrent metastatic breast cancer in four countries: A population-based study.

Journal: Breast (Edinburgh, Scotland)

Published: February 27, 2026

Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.

Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.

Journal: Journal of medical economics

Published: February 07, 2026

Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.

Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 22, 2026

Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial.

Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 22, 2026

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Journal: JAMA oncology

Published: December 18, 2025

Biomarker recall and understanding among people living with metastatic breast cancer - results from an international patient survey.

Biomarker recall and understanding among people living with metastatic breast cancer - results from an international patient survey.

Journal: Breast (Edinburgh, Scotland)

Published: December 16, 2025

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Guided Stereotactic Body Radiation Therapy in Advanced Breast Cancer Patients Treated WithCyclin-Dependent Kinase 4/6 Inhibitors.

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Guided Stereotactic Body Radiation Therapy in Advanced Breast Cancer Patients Treated WithCyclin-Dependent Kinase 4/6 Inhibitors.

Journal: Advances in radiation oncology

Published: December 02, 2025

Showing 1-12 of 206

Last Updated: 09/26/2026